The stock has a 36-month beta value of 0.66. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CVM is 75.33M, and at present, short sellers hold a 5.92% of that float. On February 27, 2025, the average trading volume of CVM was 1.28M shares.
CVM) stock’s latest price update
Cel-Sci Corp (AMEX: CVM)’s stock price has dropped by -2.25 in relation to previous closing price of 0.34. Nevertheless, the company has seen a loss of -21.77% in its stock price over the last five trading days. businesswire.com reported 2025-02-20 that VIENNA, Va.–(BUSINESS WIRE)—- $CVM #Multikine–CEL-SCI to initiate Multikine Confirmatory Phase 3 Cancer Trial.
CVM’s Market Performance
Cel-Sci Corp (CVM) has seen a -21.77% fall in stock performance for the week, with a -23.93% decline in the past month and a -44.46% plunge in the past quarter. The volatility ratio for the week is 21.41%, and the volatility levels for the past 30 days are at 13.18% for CVM. The simple moving average for the past 20 days is -16.12% for CVM’s stock, with a -63.83% simple moving average for the past 200 days.
Analysts’ Opinion of CVM
Many brokerage firms have already submitted their reports for CVM stocks, with H.C. Wainwright repeating the rating for CVM by listing it as a “Buy.” The predicted price for CVM in the upcoming period, according to H.C. Wainwright is $18 based on the research report published on January 13, 2020 of the previous year 2020.
Dawson James, on the other hand, stated in their research note that they expect to see CVM reach a price target of $3. The rating they have provided for CVM stocks is “Buy” according to the report published on March 02nd, 2015.
CVM Trading at -27.96% from the 50-Day Moving Average
After a stumble in the market that brought CVM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.75% of loss for the given period.
Volatility was left at 13.18%, however, over the last 30 days, the volatility rate increased by 21.41%, as shares sank -16.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.54% lower at present.
During the last 5 trading sessions, CVM fell by -24.26%, which changed the moving average for the period of 200-days by -78.78% in comparison to the 20-day moving average, which settled at $0.3940. In addition, Cel-Sci Corp saw -17.25% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVM starting from Watson Robert Eugene, who purchase 20,000 shares at the price of $1.39 back on May 08 ’24. After this action, Watson Robert Eugene now owns 24,431 shares of Cel-Sci Corp, valued at $27,800 using the latest closing price.
PRICHEP PATRICIA B, the Senior Vice President of Cel-Sci Corp, purchase 8,000 shares at $1.39 during a trade that took place back on May 08 ’24, which means that PRICHEP PATRICIA B is holding 232,326 shares at $11,120 based on the most recent closing price.
Stock Fundamentals for CVM
The total capital return value is set at -1.32. Equity return is now at value -227.76, with -100.29 for asset returns.
Based on Cel-Sci Corp (CVM), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at -1.63. The debt to equity ratio resting at 0.98. The interest coverage ratio of the stock is -37.27.
Currently, EBITDA for the company is -22.21 million with net debt to EBITDA at -0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.07.
Conclusion
To sum up, Cel-Sci Corp (CVM) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
